Elevated expression of CDK4 in lung cancer

Journal of Translational Medicine

Volumn 9, Issue , 2011, Pages

  Wu, Aibing ^a   Wu, Bin ^b   Guo, Jinsong ^a   Luo, Weiren ^a   Wu, Dong ^b   Yang, Huiling ^b   Zhen, Yan ^a   Yu, Xiaoli ^a   Wang, Hao ^a   Zhou, Ying ^a   Liu, Zhen ^c   Fang, Weiyi ^a   Yang, Zhixiong ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c Department of Pathology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; PROTEIN P21; CDK4 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE PROGRESSION; CLINICAL FEATURE; COLONY FORMATION; CONTROLLED STUDY; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LYMPH NODE METASTASIS; MALE; MIGRATION INHIBITION; OVERALL SURVIVAL; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL TIME; CELL CYCLE; CELL MOTION; CELL PROLIFERATION; DOWN REGULATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; LUNG; LUNG TUMOR; METABOLISM; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SURVIVAL; TUMOR CELL LINE;

CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 79953796944     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-38     Document Type: Article

References (21)

1. Houwen L. State of the art: lung cancer in China. Ann Thorac Cardiovasc Surg 2003, 9(3):147-148.
2. Miliani de Marval PL, Macias E, Conti CJ, Rodriguez-Puebla ML. Enhanced malignant tumorigenesis in Cdk4 transgenic mice. Oncogene 2004, 23(10):1863-1873. 10.1038/sj.onc.1207309, 2859671, 14647432.
3. Poomsawat S, Buajeeb W, Khovidhunkit SO, Punyasingh J. Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions. J Oral Pathol Med 2010, 39(10):793-799. 10.1111/j.1600-0714.2010.00909.x, 20618617.
4. Lindberg D, Hessman O, Akerström G, Westin G. Cyclin-dependent kinase 4 (CDK4) expression in pancreatic endocrine tumors. Neuroendocrinology 2007, 86(2):112-118. 10.1159/000106762, 17664862.
5. Wikman H, Nymark P, Väyrynen A, Jarmalaite S, Kallioniemi A, Salmenkivi K, Vainio-Siukola K, Husgafvel-Pursiainen K, Knuutila S, Wolf M, Anttila S. CDK4 is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer. Genes Chromosomes Cancer 2005, 42(2):193-199. 10.1002/gcc.20122, 15543620.
6. Dobashi Y, Goto A, Fukayama M, Abe A, Ooi A. Overexpression of cdk4/cyclin D1, a possible mediator of apoptosis and an indicator of prognosis in human primary lung carcinoma. Int J Cancer 2004, 110(4):532-541. 10.1002/ijc.20167, 15122585.
7. Fang W, Li X, Jiang Q, Liu Z, Yang H, Wang S, Xie S, Liu Q, Liu T, Huang J, Xie W, Li Z, Zhao Y, Wang E, Marincola FM, Yao K. Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J Transl Med 2008, 6:32. 10.1186/1479-5876-6-32, 2443113, 18570662.
8. Masunaga R, Kohno H, Dhar DK, Ohno S, Shibakita M, Kinugasa S, Yoshimura H, Tachibana M, Kubota H, Nagasue N. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res 2000, 6(10):4064-4068.
9. Liu Z, Li X, He X, Jiang Q, Xie S, Yu X, Zhen Y, Xiao G, Yao K, Fang W. Decreased expression of updated NESG1 in nasopharyngeal carcinoma: Its potential role and preliminarily functional mechanism. Int J Cancer 2010,
10. Lingfei K, Pingzhang Y, Zhengguo L, Jianhua G, Yaowu Z. A study on p16, pRb, cdk4 and cyclinD1 expression in non-small cell lung cancers. Cancer Lett 1998, 130(1-2):93-101. 10.1016/S0304-3835(98)00115-3, 9751261.
11. Yoshida A, Ushiku T, Motoi T, Shibata T, Beppu Y, Fukayama M, Tsuda H. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics. Mod Pathol 2010, 23(9):1279-1288. 10.1038/modpathol.2010.124, 20601938.
12. Zhang LL, Zheng C. Expression of p16 and CDK4 in colonic carcinoma and pericancerous mucose. Journal of Shenyang Medical College 2009, 11(2):74-76.
13. Ghazizadeh M, Jin E, Shimizu H, Fujiwara M, Arai S, Ohaki Y, Takemura T, Kawanami O. Role of cdk4, p16INK4, and Rb expression in the prognosis of bronchioloalveolar carcinomas. Respiration 2005, 72(1):68-73. 10.1159/000083403, 15753637.
14. Retzer-Lidl M, Schmid RM, Schneider G. Inhibition of CDK4 impairs proliferation of pancreatic cancer cells and sensitizes towards TRAIL-induced apoptosis via downregulation of survivin. Int J Cancer 2007, 121(1):66-75. 10.1002/ijc.22619, 17304504.
15. Rodriguez-Puebla ML, Miliani de Marval PL, LaCava M, Moons DS, Kiyokawa H, Conti CJ. Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation. Am J Pathol 2002, 161(2):405-411. 10.1016/S0002-9440(10)64196-X, 1850739, 12163365.
16. An HX, Beckmann MW, Reifenberger G, Bender HG, Niederacher D. Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation. Am J Pathol 1999, 154(1):113-118. 10.1016/S0002-9440(10)65257-1, 1868599, 9916925.
17. Cole AM, Myant K, Reed KR, Ridgway RA, Athineos D, Van den Brink GR, Muncan V, Clevers H, Clarke AR, Sicinski P, Sansom OJ. Cyclin D2-cyclin-dependent kinase 4/6 is required for efficient proliferation and tumorigenesis following Apc loss. Cancer Res 2010, 70(20):8149-8158. 10.1158/0008-5472.CAN-10-0315, 2974087, 20736363.
18. Larrea MD, Liang J, Da Silva T, Hong F, Shao SH, Han K, Dumont D, Slingerland JM. Phosphorylation of p27Kip1 regulates assembly and activation of cyclin D1-Cdk4. Mol Cell Biol 2008, 28(20):6462-6472. 10.1128/MCB.02300-07, 2577417, 18710949.
19. Yu X, Luo Y, Zhou Y, Zhang Q, Wang J, Wei N, Mi M, Zhu J, Wang B, Chang H, Tang Y. BRCA1 overexpression sensitizes cancer cells to lovastatin via regulation of cyclin D1-CDK4-p21WAF1/CIP1 pathway: analyses using a breast cancer cell line and tumoral xenograft model. Int J Oncol 2008, 33(3):555-563.
20. Frizelle SP, Kratzke MG, Carreon RR, Engel SC, Youngquist L, Klein MA, Fourre L, Shekels LL, Kratzke RA. Inhibition of both mesothelioma cell growth and Cdk4 activity following treatment with a TATp16INK4a peptide. Anticancer Res 2008, 28(1A):1-7.
21. Braden WA, McClendon AK, Knudsen ES. Cyclin-dependent kinase 4/6 activity is a critical determinant of pre-replication complex assembly. Oncogene 2008, 27(56):7083-7093. 27, 10.1038/onc.2008.319, 18776921.